Series B Therapeutics Companies

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.

MAXONA is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Ophelia offers medication and support for quitting opioids.

BehaVR develops evidence-based, immersive, digital therapeutics for behavioral health using Virtual Reality.

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

Cognoa is a behavioral health company.

Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.